Pinnacle Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $869K | Buy |
8,088
+404
| +5% | +$43.4K | 0.01% | 535 |
|
|
2025
Q1 | $775K | Sell |
7,684
-232
| -3% | -$23.4K | 0.01% | 530 |
|
|
2024
Q4 | $707K | Buy |
7,916
+586
| +8% | +$52.3K | 0.01% | 536 |
|
|
2024
Q3 | $424K | Sell |
7,330
-438
| -6% | -$25.3K | 0.01% | 603 |
|
|
2024
Q2 | $598K | Buy |
7,768
+290
| +4% | +$22.3K | 0.01% | 550 |
|
|
2024
Q1 | $512K | Buy |
7,478
+148
| +2% | +$10.1K | 0.01% | 581 |
|
|
2023
Q4 | $424K | Buy |
7,330
+77
| +1% | +$4.45K | 0.01% | 611 |
|
|
2023
Q3 | $383K | Sell |
7,253
-179
| -2% | -$9.45K | 0.01% | 612 |
|
|
2023
Q2 | $402K | Buy |
7,432
+343
| +5% | +$18.6K | 0.01% | 611 |
|
|
2023
Q1 | $355K | Buy |
7,089
+287
| +4% | +$14.4K | 0.01% | 589 |
|
|
2022
Q4 | $315K | Buy |
6,802
+1,189
| +21% | +$55K | 0.01% | 593 |
|
|
2022
Q3 | $217K | Buy |
+5,613
| New | +$217K | 0.01% | 677 |
|